HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Phase I, Open-Label, Dose-Escalation Study of a Human Monoclonal Antibody, VRC-HIVMAB091-00-AB (N6LS), Administered Intravenously or Subcutaneously With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20) [Phase 1]
Phase I open-label dose-escalation trial of a human monoclonal antibody (VRC-HIVMAB091-00-AB, N6LS) administered IV or subcutaneously with o…
-
CLINICAL_TRIALS trial_result · 2023-09-18Clinical Trial Update: Standard Versus Double Dose Dolutegravir in Patients With HIV-associated Tuberculosis [Phase 2]
A Phase 2 trial comparing standard-dose versus double-dose dolutegravir in people with HIV-associated tuberculosis has completed, with resul…
-
CLINICAL_TRIALS trial_result · 2023-09-18Clinical Trial Update: A Test and Treat Strategy in New HIV Diagnosis. [Phase 3]
Phase 3 clinical trial evaluating a test-and-treat strategy in newly diagnosed HIV-1 infection has completed.
-
CLINICAL_TRIALS trial_result · 2023-09-18Clinical Trial Update: A Sub-study of Cabotegravir (CAB) and Rilpivirine (RPV) in Human Immunodeficiency Viruses (HIV)-Infected Participants [Phase 3]
A Phase 3 sub-study evaluating cabotegravir and rilpivirine in HIV-1 infected participants has completed with posted results.
-
FDA approval · 2023-09-14FDA Approved: DARUNAVIR — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' generic darunavir (Darunavir) under an Original Application (ANDA202083) for HIV-1 infection. The appro…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-09-13Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Cabotegravir (CAB) Long Acting (LA) Plus (+) Rilpivirine (RPV) LA Versus BIKTARVY® (BIK) in Participants With Human Immunodeficiency Virus (HIV)-1 Who Are Virologically Suppressed [Phase 3]
Phase 3 trial evaluating long-acting cabotegravir plus long-acting rilpivirine versus Biktarvy in virologically suppressed HIV-1 patients co…
-
CLINICAL_TRIALS trial_result · 2023-09-07Clinical Trial Update: Prevention of HIV/AIDS and STDs in Women Over Fifty [Phase 2]
Phase 2 clinical trial update on prevention of HIV/AIDS and sexually transmitted diseases in women over fifty.
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: ANRS 12372 MODERATO Study [Phase 3]
Phase 3 clinical trial update for ANRS 12372 MODERATO study investigating HIV-1 infection.
-
CLINICAL_TRIALS trial_result · 2023-09-01Clinical Trial Update: A Pharmacokinetic Evaluation of Levonorgestrel Implant and Antiretroviral Therapy [Phase 2]
Phase 2 pharmacokinetic study evaluating levonorgestrel implant with antiretroviral therapy in HIV and contraception contexts; completed.
-
CLINICAL_TRIALS trial_result · 2023-08-30Clinical Trial Update: Lubiprostone as a Modulator of Gut Microbial Translocation in HIV With Incomplete CD4 Recovery on Antiretroviral Therapy [Phase 2]
Phase 2 clinical trial investigating lubiprostone as a modulator of gut microbial translocation in HIV patients with incomplete CD4 recovery…
-
CLINICAL_TRIALS trial_result · 2023-08-25Clinical Trial Update: A Clinical Trial to Evaluate the Immunogenicity of the Nonavalent Vaccine Against Human Papillomavirus in Men Infected by HIV Who Have Sex With Men. GESIDA 10017 [Phase 4]
Phase 4 trial assessing immunogenicity of the nonavalent HPV vaccine in men who have sex with men and are HIV-infected.
-
CLINICAL_TRIALS trial_result · 2023-08-23Clinical Trial Update: GSK3739937 First-Time-In-Human (FTIH) Study in Healthy Volunteers [Phase 1]
GSK3739937's first-in-human Phase 1 study in healthy volunteers for HIV infection has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Drug-drug Interaction (DDI) Study of GSK3640254 With Darunavir/Ritonavir (DRV/RTV) and Etravirine (ETR) [Phase 1]
This is a Phase 1 drug-drug interaction study evaluating the pharmacokinetic interactions of GSK3640254 with darunavir/ritonavir and with et…
-
FDA approval · 2023-08-17FDA Approved: MARAVIROC — Original Application (i3 Pharmaceuticals, LLC)
FDA approved the original application for maraviroc for treatment of HIV-1 infection.
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: Open-Label, 48-Week Extension Study of Elvucitabine in Combination With Background Antiretroviral Therapy (ART) for Participants Who Have Completed Study ACH443-014A [Phase 2]
Open-label 48-week extension study of elvucitabine with background ART in HIV-1 patients completed Phase 2.
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: A HIV Vaccine Trial in Individuals Who Started Antiretrovirals During Primary or Chronic Infection (EHVA T02) [Phase 2]
Phase 2 HIV vaccine trial in individuals who started antiretrovirals during primary or chronic infection has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Microeconomic Intervention to Reduce HIV Transmission in Economically Disadvantaged Transgender Women [NA]
A terminated clinical trial evaluating a microeconomic intervention to reduce HIV transmission among economically disadvantaged transgender …
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: RCT of an Internet Cessation Program Plus Online Social Network for HIV+ Smokers [NA]
Completed randomized trial evaluating an internet cessation program plus online social network for tobacco use disorder in HIV+ individuals;…
-
CLINICAL_TRIALS trial_result · 2023-08-03Clinical Trial Update: DORA: A Doravirine-based First-line Antiretroviral Therapy for Women of Reproductive Potential Living With HIV [Phase 3]
Phase 3 trial assessing a doravirine-based first-line antiretroviral therapy for women of reproductive potential with HIV-1 infection has co…
-
CLINICAL_TRIALS trial_result · 2023-07-28Clinical Trial Update: Online HIV Prevention for Young Male Couples [Phase 2]
Phase 2 clinical trial update for an online HIV prevention intervention aimed at young male couples; study completed.
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: Contribution of Dolutegravir to Obesity and Cardiovascular Disease [Phase 4]
A Phase 4 clinical trial evaluating the contribution of dolutegravir to obesity and cardiovascular disease in HIV-1 infection has completed.
-
CLINICAL_TRIALS trial_result · 2023-07-20Clinical Trial Update: Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant [Phase 1, Phase 2]
This update reports results from a Phase 1/2 clinical trial of a gene therapy for HIV-related lymphomas in patients undergoing stem cell tra…
-
CLINICAL_TRIALS trial_result · 2023-07-18Clinical Trial Update: B/F/TAF Switch Study for HIV-HBV Coinfection [Phase 4]
Phase 4 trial update on switching to B/F/TAF for HIV-HBV coinfection; study completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-07-12Clinical Trial Update: Multi-Component Intervention to Improve Health Outcomes and Quality of Life Among Rural Older Adults Living With HIV [NA]
A completed clinical trial evaluating a multi-component intervention to improve health outcomes and quality of life in rural older adults li…
-
CLINICAL_TRIALS trial_result · 2023-07-11Clinical Trial Update: Early Community Client-LED ART Delivery in Nakivale Refugee Settlement [NA]
A completed clinical trial evaluating early community client-led antiretroviral therapy (ART) delivery in a refugee settlement; results post…